Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 1
Abstract
Sorafenib is an oral multikinase inhibitor used as a palliative intent for advanced hepatocellular carcinoma (HCC). Dermatologic toxicity is the main adverse effect limiting its use in many patients. However, Grade III dermatologic toxicity is rarely seen with low-dose sorafenib administration. Here, we discuss the case of a 72-year-old male patient who was treated with sorafenib 400 mg for HCC. After 18 days of administration, the patient complained of intense pain with blisters and ulcerations. The drug was discontinued, and topical corticosteroids and analgesics were given for the management. Review of the patient’s medication did not reveal the presence of any other possible drugs capable of producing dermatological toxicity.
Authors and Affiliations
Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Anila K N
Keywords
Related Articles
- EP ID EP450364
- DOI 10.5455/njppp.2018.8.0725025072017
- Views 74
- Downloads 0
Intravenous catheter complications in hemodialysis
Background: Vascular access, still is a problem for hemodialysis. Venous catheters are commonly used for acute angioaccess during maintenance hemodialysis in acute renal failure and end-stage renal failure patients. Howe...
Outcome-based medical education – A brief commentary
Outcome-based education (OBE) is neither a new concept nor a passing phase in educational technology and is equally applicable throughout the educational continuum from primary school to postgraduate training. OBE emphas...
Importance of lipid-lipoprotein ratios as a diagnostic tool in metabolic syndrome population
Background: Metabolic syndrome (MS) is a constellation of diseases caused by several interconnected cardiometabolic risk factors such as obesity, hypertension, hyperglycemia, and dyslipidemia. Lipid-lipoprotein ratios ca...
Prevalence and risk factors for opportunistic infections in HIV patients who developed adverse drug reactions (ADRs) to antiretroviral therapy (ART) in a tertiary-care teaching hospital
Background: The introduction of highly active antiretroviral therapy (HAART) has led to decline in HIV-related opportunistic infections (OIs). Knowledge of the most common OI of that geographical area will help in impl...
A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient
31National Journal of Physiology, Pharmacy and Pharmacology 2018 | Vol 8 | Issue 1RESEARCH ARTICLEA six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment...